Diagnostic Testing

Biofire Blood Culture Identification (BCID) Panel - BCH Oakland

Blood Culture Rapid Identification Panel (BCID-II)

The purpose of this document is to provide general guidance for empiric therapy based on the results of the rapid blood culture identification panel (BCID-II) used at BCH Oakland. 
Please note that this is general guidance and does not replace clinical judgement based on the patient's clinical presentation, history, and current clinical status.

What is BCID? 

Rapid Gram-positive Blood Culture

These guidelines inform selection and modification of antibiotic therapy based on preliminary blood culture results. They are not intended to replace clinical judgement

Procalcitonin

Flowchart to aid in incorporating procalcitonin into considerations for initiating and discontinuing antibiotics.